Search

Laurence A Turka

from Boston, MA
Age ~67

Laurence Turka Phones & Addresses

  • 98 Pembroke St, Boston, MA 02118 (610) 390-9763
  • 79 Warren St, Boston, MA 02116 (617) 236-1149 (857) 233-5060
  • Roxbury, MA
  • Richtown Rd, Bernard, ME 04612 (207) 244-7443
  • West Tremont, ME
  • 331 Mallwyd Rd, Merion Sta, PA 19066 (610) 667-7522 (610) 667-4675
  • Merion Station, PA
  • Ann Arbor, MI
  • Trenton, ME

Work

Company: Beth israel deaconess medical center/harvard medical school Position: Physician/scientist

Industries

Biotechnology

Professional Records

Medicine Doctors

Laurence Turka Photo 1

Laurence Allan Turka, Philadelphia PA

View page
Specialties:
Internal Medicine
Nephrology
Work:
University of Pennsylvania
3400 Spruce St, Philadelphia, PA 19175
Education:
Yale University (1982)

License Records

Laurence A Turka

Address:
Boston, MA 02118
License #:
MD052593L - Expired
Category:
Medicine
Type:
Medical Physician and Surgeon

Resumes

Resumes

Laurence Turka Photo 2

Chief Scientific Officer

View page
Location:
Boston, MA
Industry:
Biotechnology
Work:
Beth Israel Deaconess Medical Center/Harvard Medical School
Physician/Scientist

Business Records

Name / Title
Company / Classification
Phones & Addresses
Laurence Allan Turka
Laurence Turka MD
Internist
3400 Spruce St, Philadelphia, PA 19104
(215) 662-2638

Publications

Us Patents

Stimulation Of Toll-Like Receptors On T Cells

View page
US Patent:
20090220528, Sep 3, 2009
Filed:
Jun 15, 2006
Appl. No.:
11/922443
Inventors:
Laurence Turka - Merion PA, US
Andrew E. Gelman - St. Louis MO, US
Assignee:
THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA CNETER FOR TECHNOLOGY TRANSFER - PHILADELPHIA
International Classification:
A61K 39/395
A61K 31/711
A61K 39/00
A61K 35/12
C12N 5/10
C12N 5/06
A61P 37/02
US Classification:
4241731, 514 44 A, 4241841, 424 937, 435325, 435375
Abstract:
The present invention relates to compositions and methods for modulating Toll-like receptors (TLRs) for enhancing survival of activated CD4+ T cells. The enhanced survival of activated CD4+ T cells provides a means for regulating an immune response.

B Cell Signature Associated With Tolerance In Transplant Recipients

View page
US Patent:
20100304996, Dec 2, 2010
Filed:
May 24, 2010
Appl. No.:
12/786068
Inventors:
Vicki Seyfert - Chevy Chase MD, US
Adam Asare - Chevy Chase MD, US
Laurence A. Turka - Boston MA, US
Kenneth Newell - Atlanta GA, US
Assignee:
Regents of the University of California - Oakland CA
University of Pennsylvania - Philidelphia PA
Emory University - Atlanta GA
International Classification:
C40B 30/04
C40B 40/08
C12Q 1/02
C40B 40/10
US Classification:
506 9, 506 17, 435 29, 506 18
Abstract:
The present invention provides methods for predicting the development of tolerance to a transplant, such as a kidney, using molecular markers that have different expression patterns in tolerant transplant recipients, as compared to non-tolerant or healthy, non-recipient controls.

Manipulation Of Pten In T Cells As A Strategy To Modulate Immune Responses

View page
US Patent:
20070048293, Mar 1, 2007
Filed:
May 31, 2006
Appl. No.:
11/444695
Inventors:
Laurence Turka - Merion Station PA, US
Steven Bensinger - Los Angeles CA, US
Patrick Walsh - Philadelphia PA, US
International Classification:
A61K 48/00
C07H 21/02
C12N 5/08
A61K 9/127
C12N 15/88
US Classification:
424093210, 435372000, 435458000, 424450000, 536023100
Abstract:
The present invention relates to compositions and methods for modulating the expression and/or activity of PTEN in T cells, regulatory T cells, and CD4 T cells. The manipulation of PTEN provides a means for regulating an immune response.
Laurence A Turka from Boston, MA, age ~67 Get Report